Pfizer’s Talzenna approved for breast cancer treatment
By Rajaneesh K Gopinath The PARP inhibitor receives an earlier than expected nod from the FDA which aptly falls on the Breast Cancer Awareness Month (BCAM) of October by coincidence. …
Read More